These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 14073326)

  • 1. [THE USE OF DOPAN AND MYELOSAN IN THE TREATMENT OF PATIENTS WITH CHRONIC MYELOLEUKEMIA].
    SPASSKII OV
    Sov Med; 1963 May; 26():30-3. PubMed ID: 14073326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Result of use of dopan in treatment of chronic myeloleukosis].
    MOKEEVA RA
    Sov Med; 1958 Sep; 22(9):42-6. PubMed ID: 13615483
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immediate and remote results of treatment of patients with chronic myeloid leukosis with myelosan].
    GUREVICH LI
    Sov Med; 1960 Oct; 24():84-8. PubMed ID: 13709851
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of chronic myeloleukosis with myelosan.
    PAVLOVSKAIA NI
    Klin Med (Mosk); 1958 Jul; 36(7):82-8. PubMed ID: 13576705
    [No Abstract]   [Full Text] [Related]  

  • 5. Method of treatment of chronic myeloleukosis with myelosan.
    MOKEEVA RA
    Klin Med (Mosk); 1958 Jul; 36(7):89-93. PubMed ID: 13576706
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinico-laboratory data in myelosan therapy of patients with chronic myeloleukoses].
    RUSOVA AI
    Klin Med (Mosk); 1960 Jul; 38():128-31. PubMed ID: 13744812
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of the kinetic method for evaluation of the effectiveness of treating chronic leukemia patients with myelosan and degranol and their effect on the hemogram].
    Bala IuM; Rosnovskiĭ VS; Biriukova IV
    Probl Gematol Pereliv Krovi; 1971 May; 16(5):14-6. PubMed ID: 5292230
    [No Abstract]   [Full Text] [Related]  

  • 8. [Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan].
    Levitin EI; Kukharenko IuA; Evsenko LS; Emanuel' NM
    Izv Akad Nauk SSSR Biol; 1968; 5():739-43. PubMed ID: 5262634
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis].
    CHERNOV VA
    Klin Med (Mosk); 1958 Jul; 36(7):73-82. PubMed ID: 13576704
    [No Abstract]   [Full Text] [Related]  

  • 10. [The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis].
    Klimova NF; Cherntsova TA; Protasova TG
    Sov Med; 1967 Dec; 30(12):67-71. PubMed ID: 5250006
    [No Abstract]   [Full Text] [Related]  

  • 11. EFFECT OF DRUGS ON CELLS IN VITRO.
    ONESTI P; WOODLIFF HJ
    Br Med J; 1963 Dec; 2(5371):1534. PubMed ID: 14063095
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of nitrogen mustard on the oxygen consumption of the leukocytes in chronic myeloid leukemia].
    PISANI A; POGGI C; MEARDI G
    Boll Soc Ital Biol Sper; 1960 Aug; 36():750-2. PubMed ID: 13736043
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the tactics of myelosan therapy of chronic myeloleukosis].
    Kassirskiĭ IA; Volkova MA
    Ter Arkh; 1967 Feb; 39(2):3-9. PubMed ID: 5252300
    [No Abstract]   [Full Text] [Related]  

  • 14. [Complications during chemotherapy of chronic myeloleukemia].
    MIKHAILOVA NS; RYBKIN IN
    Klin Med (Mosk); 1957 Dec; 35(12):112-5. PubMed ID: 13540084
    [No Abstract]   [Full Text] [Related]  

  • 15. Myleran in the treatment of chronic lymphatic leukemia.
    Bean RH
    Isr J Med Sci; 1965 Jul; 1(4):801-5. PubMed ID: 5856121
    [No Abstract]   [Full Text] [Related]  

  • 16. First results of dopane therapy of chronic myeloid leukemia and of certain malignant tumors.
    VISHNIAKOVA EG
    Vopr Onkol; 1958; 4(5):569-72. PubMed ID: 13625640
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of subleukemic myeloleukosis with Dopan].
    Morozova VT; Miroshnichenko IS; Terent'eva NI
    Ter Arkh; 1967 Feb; 39(2):19-20. PubMed ID: 5611685
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of chronic myeloid leukemia with 1, 4-butanediol dimethylsulfonyl ester (busulfan)].
    BEROVIC R; BUGARSKI M; KONECNI J
    Srp Arh Celok Lek; 1956 May; 84(5):571-84. PubMed ID: 13391224
    [No Abstract]   [Full Text] [Related]  

  • 19. Some aspects of the mechanism of action of derivatives of myleran and nitrogen mustard.
    TALBOT TR
    Trans Am Clin Climatol Assoc; 1957-1958; 69():113-7. PubMed ID: 13581093
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
    Volkova SA; Prytkova MV; Borovkov NN
    Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.